<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Forty-three patients with hematopoietic disease were treated with intensive chemotherapy and radiotherapy, followed by allogeneic bone marrow transplantation (BMT) from 28 HLA-identical and 10 one to two antigen haploidentical sibling donors and autologous BMT (5 cases) </plain></SENT>
<SENT sid="1" pm="."><plain>Of these cases, there were 21 with <z:hpo ids='HP_0011009'>acute</z:hpo> nonlymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ANLL), 5 with <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ALL), 6 with <z:hpo ids='HP_0011010'>chronic</z:hpo> myelocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), 2 with <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>), 8 with severe-form <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) and 1 with <z:e sem="disease" ids="C0039730" disease_type="Disease or Syndrome" abbrv="">thalassemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Complications of BMT were evaluated including <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> (GVHD), interstitial <z:hpo ids='HP_0002090'>pneumonia</z:hpo> (IP), veno-occlusive <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VOD</z:e>), abnormalities of liver function (LF), and alteration of <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B virus (HBV) markers </plain></SENT>
<SENT sid="3" pm="."><plain>In thirty-three patients who were followed up for more than 3 months, we found that the incidence of moderate to severe <z:hpo ids='HP_0011009'>acute</z:hpo> GVHD (9.1%) and IP (two cases, 4.7%) were low </plain></SENT>
<SENT sid="4" pm="."><plain>No <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VOD</z:e> occurred in our series </plain></SENT>
<SENT sid="5" pm="."><plain>During the follow-up period, 27 out of 35 patients (77%) had high alanine aminotransferase (ALT)/<z:chebi fb="0" ids="29995">aspartate</z:chebi> aminotransferase (AST) levels, even up to 1000 U/liter; however, only one patient succumbed to a <z:hpo ids='HP_0012115'>hepatitis</z:hpo>-related complication </plain></SENT>
<SENT sid="6" pm="."><plain>Previous hepatic damage from HBV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> before BMT does not appear to increase the risk of posttransplant morbidity and mortality </plain></SENT>
</text></document>